AVR — Anteris Technologies Global Corp.
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 2011514 ·
Last close
$5.32
Market Cap
$518.67M
52W High
$11.06
52W Low
$3.30
ADV30
1,492,264
Next earnings
2026-11-12
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 519,000 | 393,000 | -29,841,000 | -26,826,000 | 262,465,000 | 232,299,000 | 35,411,000 |
| Jun 2026 | 1,009,000 | 776,000 | -30,997,000 | -29,094,000 | 272,507,000 | 256,867,000 | 20,837,000 |
| Mar 2026 | 494,000 | 380,000 | -24,007,000 | -23,024,000 | 294,722,000 | 282,699,000 | 16,311,000 |
| Dec 2025 | 310,000 | 219,000 | -29,207,000 | -29,202,000 | 22,997,000 | — | 23,250,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-90,900,000
Investing CF
$-2,622,000
Financing CF
$320,752,000
CapEx
$-2,622,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-1.48
As of
2026-11-15
Balance + Analyst (yfinance extras)
Retained Earnings
$-449,476,000
Inventory
$0
Receivables
$220,000
ST Investments
—
EBIT TTM
$-107,119,000
Pretax Income TTM
$-107,304,000
Interest Exp TTM
$185,000
Analysts
4
Yahoo Snapshot (yfinance, live)
Total Revenue
$2,332,000
EBITDA
$-111,993,000
Free Cash Flow
$-59,060,876
Enterprise Value
$312,514,400
Total Cash
$232,299,008
Total Debt
$16,116,000
Shares Out
97,493,429
Trailing EPS
$-1.60
Book Value
$2.33
ROE
-93.3%
ROA
-50.5%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 1,913,000 | -94,136,000 | -94,144,000 | 22,997,000 | 23,250,000 | -93,000 | -77,803,000 |
| Dec 2024 | 2,703,000 | -77,329,000 | -76,291,000 | 80,699,000 | 18,017,000 | 62,761,000 | -61,241,000 |
| Dec 2023 | 2,800,884 | -48,122,276 | -45,874,304 | 31,136,343 | 11,608,797 | 19,486,580 | — |
| Dec 2022 | 3,122,608 | -32,236,540 | -30,164,606 | 15,973,036 | 6,980,985 | 8,992,051 | — |
| Dec 2021 | — | — | — | — | — | — | — |
TTM Snapshot
Revenues TTM
$2,242,000
NetIncome TTM
$-103,564,000
OpCashFlow TTM
—
Assets (Latest)
$272,507,000
Forward EPS
$-1.11
Max Pain — expiry 2027-02-19
max pain strike: $5.00 · spot: $5.21 · call oi: 1,934 · put oi: 358
Expected Move to 2027-02-19:
±$1.88
(35.99%) —
implied range
$3.33 –
$7.08
· ATM straddle on $5.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| RCEL | AVITA Medical, Inc. | $495.50M | $15.77 | — |
| OBIO | Orchestra BioMed Holdings, Inc. | $548.57M | $6.97 | — |
| AVHHL | AVITA Medical, Inc. | $549.85M | $3.50 | — |
| CARL | CARLSMED, INC. | $486.15M | $17.74 | — |
| ANGO | ANGIODYNAMICS INC | $483.21M | $11.49 | — |
News headlines (Yahoo Finance, 1h cache)
Anteris Announces Late-Breaking PCR London Valves Data Release: One-Year DurAVR THV Outcomes in 100 Patients
2026-11-16 11:00 · Yahoo
Small cap Snapshot: Anteris expands trial, PilbaraGold expands mineralsiation and more...
2026-11-11 04:51 · Yahoo
Anteris Technologies advances PARADIGM trial and manufacturing scale-up in third quarter
2026-11-10 23:44 · Yahoo
Anteris Technologies Announces Results for the Third Quarter of 2026
2026-11-10 22:28 · Yahoo
Anteris Technologies reports strong 30-day DurAVR heart valve outcomes from EMBARK Study
2026-11-01 23:05 · Yahoo
Small Cap watch: ASX small caps ease after strong week as NewPeak, Orthocell and Anteris advance drilling, sales and data
2026-11-01 22:58 · Yahoo
Anteris Reports Medium-Size DurAVR THV Outcomes from the EMBARK Study at TCT 2026
2026-11-01 19:59 · Yahoo
Anteris Announces Upcoming Data Release for Medium-Size DurAVR THV from EMBARK Study at TCT 2026
2026-10-27 10:00 · Yahoo
Anteris Technologies secures German clearance to expand PARADIGM heart valve trial
2026-10-20 02:02 · Yahoo
Anteris Advances Global PARADIGM Trial Expansion with German Regulatory Clearance
2026-10-20 01:12 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.